Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD
SZSE:300534.SZ
9.22 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 288.945 | 97.834 | 99.121 | 118.189 | 51.634 | 63.029 | 58.586 | 124.303 | 142.042 | 183.827 | 233.025 | 120.972 | 9.631 |
| Short Term Investments
| 0 | -112.206 | -79.656 | -64.497 | -66.464 | -68.432 | -20.097 | 0 | 4.562 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 288.945 | 97.834 | 99.121 | 118.189 | 51.634 | 63.029 | 58.586 | 124.303 | 142.042 | 183.827 | 233.025 | 120.972 | 9.631 |
| Net Receivables
| 243.302 | 0 | 140.441 | 169.814 | 183.311 | 175.507 | 163.143 | 136.651 | 94.014 | 46.272 | 50.876 | 45.913 | 0 |
| Inventory
| 97.4 | 63.389 | 55.697 | 41.554 | 39.707 | 32.435 | 24.301 | 16.4 | 42.285 | 54.11 | 55.153 | 69.237 | 43.672 |
| Other Current Assets
| 17.35 | 0.204 | 13.441 | 3.544 | 4.609 | 2.666 | 15.743 | 4.899 | 8.62 | 40.08 | 25.337 | 25.921 | 39.002 |
| Total Current Assets
| 646.998 | 402.587 | 308.7 | 333.101 | 279.261 | 273.656 | 261.773 | 282.252 | 286.961 | 326.152 | 365.712 | 262.042 | 92.305 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 439.418 | 267.907 | 305.205 | 326.763 | 312.984 | 310.381 | 382.699 | 349.671 | 355.211 | 150.25 | 86.096 | 30.077 | 25.966 |
| Goodwill
| 13.724 | 13.724 | 13.724 | 18.507 | 18.507 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 62.073 | 54.737 | 50.744 | 52.007 | 52.154 | 53.336 | 46.804 | 51.773 | 1.615 | 1.642 | 1.708 | 1.89 | 1.862 |
| Goodwill and Intangible Assets
| 75.797 | 68.461 | 64.468 | 70.514 | 70.661 | 53.336 | 46.804 | 51.773 | 1.615 | 1.642 | 1.708 | 1.89 | 1.862 |
| Long Term Investments
| 54.2 | 166.406 | 133.856 | 118.697 | 120.664 | 122.632 | 74.297 | 54.2 | -2.562 | -0.449 | -0.443 | 0 | 0 |
| Tax Assets
| 10.118 | 7.25 | 5.768 | 6.012 | 2.852 | 3.061 | 2.798 | 1.352 | 0.955 | 0.449 | 0.443 | 0.517 | 0.363 |
| Other Non-Current Assets
| 110.121 | 0.182 | 6.075 | 11.575 | 23.724 | 15.448 | 13.859 | 24.228 | 4.562 | 0.449 | 0.443 | 0 | 0 |
| Total Non-Current Assets
| 689.654 | 510.206 | 515.373 | 533.56 | 530.886 | 504.858 | 520.457 | 481.224 | 359.781 | 152.341 | 88.246 | 32.485 | 28.19 |
| Total Assets
| 1,336.651 | 912.793 | 824.073 | 866.661 | 810.146 | 778.514 | 782.23 | 763.476 | 646.742 | 478.493 | 453.959 | 294.527 | 120.495 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 243.561 | 209.011 | 32.633 | 6.528 | 20.275 | 21.618 | 32.966 | 25.528 | 31.96 | 27.198 | 64.395 | 76.303 | 33.209 |
| Short Term Debt
| 30.033 | 0 | 0 | 70.066 | 24.034 | 10 | 0 | 0 | 20 | 0 | 0 | 0 | 6.5 |
| Tax Payables
| 30.373 | 15.807 | 6.417 | 6.287 | 4.158 | 1.324 | 4.063 | 3.999 | 7.621 | 5.287 | 4.393 | 3.311 | 3.593 |
| Deferred Revenue
| 0 | 9.058 | 13.776 | 25.896 | 12.902 | 11.125 | 4.821 | 7.151 | 10.761 | 0 | 0 | 0 | 20.73 |
| Other Current Liabilities
| 181.171 | 182.501 | 29.266 | -5.295 | 18.413 | 7.75 | 15.648 | 10.554 | -3.024 | 10.816 | 8.205 | 16.327 | 24.645 |
| Total Current Liabilities
| 485.139 | 127.393 | 68.316 | 103.481 | 66.88 | 51.817 | 52.678 | 40.081 | 67.318 | 43.301 | 76.993 | 95.941 | 67.948 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 113.313 | 0 | 0 | 0 | 0 | 0 | 10 | 10 | 150 | 50 | 50 | 20 | 0 |
| Deferred Revenue Non-Current
| 26.445 | 22.268 | 22.921 | 24.043 | 4.375 | 5.867 | 7.359 | 9.659 | 13.851 | 12.043 | 8.044 | 7.127 | 0 |
| Deferred Tax Liabilities Non-Current
| 0.244 | 0 | 0 | 0.004 | 0.007 | 0 | -7.359 | -9.659 | -140 | -39.947 | -8.044 | -7.127 | 0 |
| Other Non-Current Liabilities
| 0 | 4.625 | 22.921 | 0 | 0 | 0 | 0 | 0 | 23.851 | 22.096 | 0 | 0 | 7.201 |
| Total Non-Current Liabilities
| 140.002 | 22.268 | 22.922 | 24.047 | 4.382 | 5.867 | 17.359 | 19.659 | 173.851 | 72.096 | 58.044 | 27.127 | 7.201 |
| Total Liabilities
| 625.141 | 149.661 | 91.237 | 127.528 | 71.262 | 57.684 | 70.037 | 59.74 | 241.169 | 115.397 | 135.037 | 123.068 | 75.148 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 303.345 | 303.345 | 303.345 | 303.345 | 303.345 | 303.345 | 303.345 | 86.67 | 65 | 65 | 65 | 45 | 25 |
| Retained Earnings
| 233.018 | 181.746 | 156.498 | 165.605 | 166.813 | 158.109 | 150.803 | 170.092 | 127.394 | 91.154 | 53.005 | 27.361 | 10.95 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 29.497 | 28.918 | 28.918 | 28.912 | 27.889 | 26.556 | 24.823 | 20.269 | -0 | -0 | 0 | 0 |
| Other Total Stockholders Equity
| 97.343 | 353.498 | 260.407 | 260.407 | 260.4 | 259.361 | 258.044 | 422.151 | 213.179 | 206.942 | 208.924 | 99.099 | 9.223 |
| Total Shareholders Equity
| 633.706 | 746.077 | 720.25 | 729.356 | 730.559 | 720.831 | 712.193 | 703.736 | 405.573 | 363.096 | 318.922 | 171.46 | 45.173 |
| Total Equity
| 711.511 | 763.132 | 732.835 | 739.134 | 738.884 | 720.831 | 712.193 | 703.736 | 405.573 | 363.096 | 318.922 | 171.46 | 45.346 |
| Total Liabilities & Shareholders Equity
| 1,336.651 | 912.793 | 824.073 | 866.661 | 810.146 | 778.514 | 782.23 | 763.476 | 646.742 | 478.493 | 453.959 | 294.527 | 120.495 |